NSCLC with SMARCA4 mutations displays a high mutation burden, so SMARCA4 mutations are associated with the sensitivity of ICIs and are expected to be one of the predictive biomarkers of ICIs. Here, SMARCA4 is linked to non-small cell lung carcinoma.